IP Library › Granted Patent US 11,717,537
Granted Patent B2
US 11,717,537 · App. 17/832,556 · Granted Aug 8, 2023

Compositions and methods for dental mineralization

Inventor: Eric Charles Reynolds (Carlton, AU)
Assignee: THE UNIVERSITY OF MELBOURNE
A61K33/42A61K8/21A61K8/24A61K8/64A61K9/0058A61K47/42A61Q11/00A61K2800/28A61K2800/592
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,717,537
App. No.
17/832,556
Granted
Aug 8, 2023
Kind
B2
Abstract

The present invention relates to compositions for mineralizing a dental surface, in particular tooth enamel. Methods of mineralizing hypomineralized lesions (including subsurface lesions) in the tooth enamel caused by dental caries, dental corrosion and fluorosis are also provided. In particular, the invention relates to a method of mineralizing a dental surface or subsurface comprising contacting the dental surface or subsurface with a compound that is capable of increasing or maintaining the pH of a solution and a mineralizing agent.

Claims (19)

1. A method of reducing white spot lesions on tooth enamel or subsurface in a patient in need thereof, comprising

(i) contacting a white spot lesion with a first composition comprising one or more mineralizing agents selected from stabilized amorphous calcium phosphate (ACP) and stabilized amorphous calcium fluoride phosphate (ACFP), and

(ii) subsequently to (i) and within 1 to 60 minutes of (i), contacting the white spot lesion with a second composition comprising a base, thereby reducing the white spot lesion.

2. The method of claim 1 , wherein the stabilized ACP and/or stabilized ACFP are contacted with the white spot lesion for a period of time selected from about 1 minute to 2 hours, about 5 minutes to 60 minutes, and about 10 minutes.

3. The method of claim 1 , wherein the second composition is contacted with the white spot lesion for a period of time selected from about 1 to 60 minutes, about 1 to 30 minutes, and about 20 minutes.

4. The method of claim 1 , wherein the stabilized ACP and/or stabilized ACFP is repeatedly applied to the white spot lesion.

5. The method of claim 4 , wherein the stabilized ACP and/or stabilized ACFP is repeatedly applied to the white spot lesion over a period of 1 day to several months.

6. A method according to claim 1 , wherein the stabilized ACP and/or stabilized ACFP is in a form selected from a toothpaste, toothpowder, liquid dentifrice, mouthwash, mouthrinse, mouth spray, varnish, dental cement, troche, chewing gum, lozenge, dental paste, gingival massage cream, gargle tablet, dairy product, and other foodstuffs.

7. A method according to claim 1 , wherein the second composition is capable of maintaining the pH of a solution between 7 to 9.

8. A method according to claim 1 , wherein the second composition is capable of maintaining the pH of a solution at about 7.5.

9. A method according to claim 1 , wherein the second composition is provided in an amount effective to raise the pH of intra-lesion fluid of a dental lesion from 6 to 7.5.

10. A method according to claim 1 , wherein the base is selected from sodium bicarbonate, sodium hypochlorite, and urea.

11. A method according to claim 7 , wherein the second composition is in a form selected from a mouthrinse comprising sodium bicarbonate and a mouthwash comprising sodium bicarbonate.

12. A method according to claim 1 , wherein the contacting of step (ii) is effected 1 to 30 minutes after the contacting of step (i).

13. A method according to claim 1 , wherein the contacting of step (ii) is effected 1 to 5 minutes after the contacting of step (i).

14. A method according to claim 1 , wherein the stabilized ACP is casein phosphopeptide stabilized amorphous calcium phosphate (CP-ACP).

15. A method according to claim 1 , wherein the stabilized ACFP is casein phosphopeptide stabilized amorphous calcium fluoride phosphate (CP-ACFP).

16. A method according to claim 1 , wherein the stabilized ACP is casein phosphopeptide stabilized amorphous calcium phosphate (CP-ACP) and the stabilized ACFP is casein phosphopeptide stabilized amorphous calcium fluoride phosphate (CP-ACFP).

17. A method according to claim 1 , wherein the base is sodium hydroxide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2024
From: REYNOLDS, ERIC CHARLES
To: THE UNIVERSITY OF MELBOURNE
Reel/Frame 068089/0836 →
Priority Claims (1)
AU 2013902815 · Jul 23, 2013 · national
Continuity (3)
Continuation 16852983 · Apr 20, 2020
Continuation 14906395
Related Publication 20220401473A1 · Dec 22, 2022
Cited By (4)
US 12,239,723 US 12,303,548 US 12,551,417 US 12,569,417